Treatment of dyslipidemia in the elderly: understanding cardiovascular risk tables and when to start treatment
2023
Abstract
Despite recent decline, cardiovascular diseases remain the main cause of mortality and morbidity and their occurrence is increasing with age. Dyslipidaemia represents a basic risk factor for cardiovascular disease.
Dyslipidaemia treatment initiation depends on patient risk stratification. In older patients with documented cardiovascular disease, treatment is recommended in the same way as in younger patients.
In older patients without documented cardiovascular disease, treatment should be considered in very-high-risk patients about estimated life expectancy, patient adherence, drug interactions, geriatric frailty and patient preference.